The decrease of CSF glucose in TBM patients may be due to the release of glycolytic enzymes from the brain and the consumption of glucose, whereas the cause of the decrease of glucose in A-GFAP-A patients remains unknown. This evidence concerns the gene GFAP and meningeal tuberculosis.